289 related articles for article (PubMed ID: 19645665)
21. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.
Jüttermann R; Li E; Jaenisch R
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11797-801. PubMed ID: 7527544
[TBL] [Abstract][Full Text] [Related]
22. Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.
Mund C; Hackanson B; Stresemann C; Lübbert M; Lyko F
Cancer Res; 2005 Aug; 65(16):7086-90. PubMed ID: 16103056
[TBL] [Abstract][Full Text] [Related]
23. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
To KK; Zhan Z; Bates SE
Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
[TBL] [Abstract][Full Text] [Related]
24. Clinical development of demethylating agents in hematology.
Navada SC; Steinmann J; Lübbert M; Silverman LR
J Clin Invest; 2014 Jan; 124(1):40-6. PubMed ID: 24382388
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
Bender CM; Pao MM; Jones PA
Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
[TBL] [Abstract][Full Text] [Related]
26. Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase.
Jackson-Grusby L; Laird PW; Magge SN; Moeller BJ; Jaenisch R
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4681-5. PubMed ID: 9114051
[TBL] [Abstract][Full Text] [Related]
27. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
[TBL] [Abstract][Full Text] [Related]
28. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
Patel K; Dickson J; Din S; Macleod K; Jodrell D; Ramsahoye B
Nucleic Acids Res; 2010 Jul; 38(13):4313-24. PubMed ID: 20348135
[TBL] [Abstract][Full Text] [Related]
29. Increased cell proliferation and R.Msp1 fragmentation induced by 5-aza-2'-deoxycytidine in rat testes related to the gene imprinting mechanism.
Ozdemir O; Bulut HE; Korkmaz M; Onarlioglu B; Colak A
Exp Toxicol Pathol; 2000 Aug; 52(4):317-22. PubMed ID: 10987184
[TBL] [Abstract][Full Text] [Related]
30. Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance.
Michalowsky LA; Jones PA
Mol Cell Biol; 1987 Sep; 7(9):3076-83. PubMed ID: 2444874
[TBL] [Abstract][Full Text] [Related]
31. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
[TBL] [Abstract][Full Text] [Related]
32. 5-Aza-2'-deoxycytidine stimulates inducible nitric oxide synthase induction in C6 astrocytoma cells.
Cvetkovic I; Popadic D; Vuckovic O; Harhaji Lj; Miljkovic Dj; Trajkovic V
Brain Res; 2004 Feb; 998(1):83-90. PubMed ID: 14725971
[TBL] [Abstract][Full Text] [Related]
33. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
Stresemann C; Lyko F
Int J Cancer; 2008 Jul; 123(1):8-13. PubMed ID: 18425818
[TBL] [Abstract][Full Text] [Related]
34. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Chuang JC; Yoo CB; Kwan JM; Li TW; Liang G; Yang AS; Jones PA
Mol Cancer Ther; 2005 Oct; 4(10):1515-20. PubMed ID: 16227400
[TBL] [Abstract][Full Text] [Related]
35. Hairpin-bisulfite sequencing of cells exposed to decitabine documents the process of DNA demethylation.
Mayyas IM; Weeks RJ; Day RC; Magrath HE; O'Connor KM; Kardailsky O; Hore TA; Hampton MB; Morison IM
Epigenetics; 2021 Nov; 16(11):1251-1259. PubMed ID: 33315501
[TBL] [Abstract][Full Text] [Related]
36. Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.
Stewart DJ; Issa JP; Kurzrock R; Nunez MI; Jelinek J; Hong D; Oki Y; Guo Z; Gupta S; Wistuba II
Clin Cancer Res; 2009 Jun; 15(11):3881-8. PubMed ID: 19470736
[TBL] [Abstract][Full Text] [Related]
37. Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma.
Majumder S; Ghoshal K; Datta J; Bai S; Dong X; Quan N; Plass C; Jacob ST
J Biol Chem; 2002 May; 277(18):16048-58. PubMed ID: 11844796
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic hierarchy governing Nestin expression.
Han DW; Do JT; Araúzo-Bravo MJ; Lee SH; Meissner A; Lee HT; Jaenisch R; Schöler HR
Stem Cells; 2009 May; 27(5):1088-97. PubMed ID: 19415779
[TBL] [Abstract][Full Text] [Related]
40. Azacytidine causes complex DNA methylation responses in myeloid leukemia.
Stresemann C; Bokelmann I; Mahlknecht U; Lyko F
Mol Cancer Ther; 2008 Sep; 7(9):2998-3005. PubMed ID: 18790780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
